Breast Cancer Clinical Trials in Cleveland

Showing 601-605 of 605 trials

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

NCT00328432

To assess the effects of short term administration of celecoxib 400 mg bid between biopsy and reexcision.

University of Kansas100 participantsStarted Jun 2003

Birmingham, Alabama, United States • Palm Springs, California, United States • Maywood, Illinois, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

NCT00081796

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Breast CancerMetastases

Sanofi438 participantsStarted Apr 2004

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +184 more locations

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Breast Cancer Trials in Other Cities

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Study of Alimta and Epirubicin Administered in Patients With Locally Advanced or Metastatic Breast Cancer

Other Conditions in Cleveland